The electroporation system for cells mixture monitored by morphometric analysis of the hybrid picture

• Autorzy: Dyszkiewicz A. , Wróbel Z. , Sławiec M.
• Języki publikacji: EN

Abstrakty

EN

The outline of issues connected with contemporary application of monoclone antibodies and techniques for obtaining hybrids was presented in the study. The results of research concerning modifications of Zimmerman's methods were obtained. They prove higher efficacy and selectivity of the solution proposed. The system of electroporation with changed geometry of electrodes and parameters of current is being proposed. The procedure is controlled entirely by microprocessor, from the stage of technology parameters' control in incubators of initial cells to creation of appointed mixture of cells in a mixer, and then division into portions, pumping the mixture into hybridisation chamber and, after hybridisation, pumping the mixture over into separate sections of incubator. The hybridisation system was modified. Transparent water coat was constructed. It was connected to thermostat, on which transparent hybridisation chamber was installed. Lighting from underneath and gap lighting of chamber enable continuous observation of suspended cells by means of microscope lens being connected by picture channel to computer. The software analyses the picture with respect to hybrid selection. The cells marked are planimctrically analysed during the time which was programmed. When the morphometric criteria are met suspended cells are pumped over to separate sections of incubator, where selective breeding of hybrids is carried out. Selection of hybrids takes place in electroosmosis gradient under morphometric control of cells in microcapillary systems.

Słowa kluczowe

EN

cell; medical research; electroporation process; survey hybridisation chamber

PL

komórka; badania medyczne

• Wydawca: Oficyna Wydawnicza Politechniki Wrocławskiej
• Czasopismo: Acta of Bioengineering and Biomechanics
• Rocznik: 2002
• Tom: Vol. 4, nr 2
• Strony: 91--99
• Opis fizyczny: Bibliogr. 32 poz., rys.

Twórcy

autor

Dyszkiewicz A.

• University of Silesia, Computer Science Department [Politechnika Śląska], Śnieżna 2, 41-200 Sosnowiec

autor

Wróbel Z.

• University of Silesia, Computer Science Department [Politechnika Śląska], Śnieżna 2, 41-200 Sosnowiec

autor

Sławiec M.

• University of Silesia, Computer Science Department [Politechnika Śląska], Śnieżna 2, 41-200 Sosnowiec

Bibliografia

• [1] BADKAR A., B ETAGERI G., HOFMANN G., Enhancement on transdermal iontophoretic delivery of a liposomal formulation of colchicine by electroporation, Drug Deliv., 1999, 6, 111.
• [2] BANGA A., PRAUSNITZ M., Assessing the potential of skin electroporation for the delivery of protein and gene based drugs, Trends in Biotech., 1998, 16, 408.
• [3] BANING A., BREWER L., WENDT M., Local delivery of platelets with encapsulated iloprost to balloon injured pig carotid arteries effect of platelet deposition and neointima formation, Thromb Haemost, 1997, 77(1), 190.
• [4] CHANG S., HOFMANN G., Z HANG L., Transdermal ionophoretic delivery on salomon calcitonin, Int. J. Pharmac., 2000, 200, 107.
• [5] CHAZAL M., BENCHIMOL D., BERNARD J., Treatment of liver metastases from colorectal cancer by electrochemotherapy, Annual Cancer Symposium Society of Surgical Oncology, 1998, 35, W18.
• [6] CUI J., ROBINSON K., BROWN J., Local drug delivery to pig carotid arteries by direct vessel wall electroporation using a novel catather, Proceedings of of the American College of Cardiology, 1997, 29(2), 201A, 749.
• [7] DEV S., GIORDANO F., BROWN D., Can endoluminal gene delivery by pulsed electric field overcome the current deficiences of gene therapy for cardiovascular diseases, Proceed. Bioelectrochem. Bioenerg., 1996, 113.
• [8] DEV S., HOFMANN G., Electrochemotherapy a novel method of cancer treatment, Cancer Treat Rev., 1994, 20, 105.
• [9] DEV S., NANDA G., Electrochemotherapy – what does the future hold? Results from treatment of human pancreatic and non-small cell lung cancer xenografted onto nude mice, Proceed. Bioelectrochem. Bioenerg., 1996, 143.
• [10] DEV S., Electrochemotherapy for cancer, Cancer Watch, 1996, 5(2), 23.
• [11] DEV S., Killing cancer cells with a combination of pulsed electric fields and chemotherapeutic agents, Cancer Watch, 1994, 3, 12.
• [12] DYSZKIEWICZ A., Komora do elektrofonoforezy, Urząd Patentowy RP, 10/1998, W 108753.
• [13] DYSZKIEWICZ A., Komora do hybrydyzacji komórek oraz diagnostyki płynów ustrojowych, Urząd Patentowy RP P 328254.
• [14] DYSZKIEWICZ A., GAŹDZIK T., BARAŃSKA T., Drug penetration into muscle tissue after phonophoresis, ionophoresis and electrophonophoresis, Acta Bioeng. Biomech., 1999, 1, suppl 1, 125.
• [15] DYSZKIEWICZ A., SAPOTA G., WRÓBEL Z., Wielofunkcyjne sterowanie procesem elektrofonoforezy w terapii zespołów bólowych kręgosłupa, II Sympozjum MPM, Krynica Górska, 8–12.05.2000, 131.
• [16] DYSZKIEWICZ A., I MIELSKI K., Klinicke a laboratorni hodnoceni penetrace leku v procesu elektrofonoforezy, Rehabil Fizik Lekar, 2000, 4.
• [17] DYSZKIEWICZ A., GAŹDZIK T., Ocena penetracji leków w tkance mięśniowej po zastosowaniu elektrofonoforezy, Post. Rehab., 1999, 4.
• [18] DYSZKIEWICZ A., WRÓBEL Z., Elektromagnetoforeza presyjno-rotacyjna, Urząd Patentowy RP, 01/2001.
• [19] DYSZKIEWICZ A., WRÓBEL Z., Reversible remote modification of the skine penetration for ions and particles based on the presso-rotation electromagnetophoresis, Int. Symp. Biophys. Med., Cieszyn, 2001.
• [20] E ISENBARTH G., Application of monoclonal antibody techniques to biochemical research, Anal. Biochem., 1981, 3, 1–16.
• [21] E ISENBARTH G., JACKSON R., Application of monoclonal antibody techniques to endocrinology, Endoc. Rev., 1982, 1, 26.
• [22] GLASS L., PEPINE M., FENSKE N., Bleomycin mediated electrochemotherapy of metastatic melanoma, Arch, Dermatol., 1996, 132, 1353. The electroporation systems for cells mixture 99
• [23] HELLER R., JAROSZESKI M., ATKIN A., Electrically enhanced delivery of molecules to cells, Proceedings of the Congress on in Vitro Biology, 1997.
• [24] HELLER R., JAROSZESKI M., PERROTT R., Effective treatment of B16 melanoma by direct delivery of bleomycin using electrochemotherapy, Melanoma Research, 1997, 7, 10.
• [25] HOFMANN G., DEV S., NANDA G., Electrochemotherapy – transition from laboratory to the clinic, IEEE Eng. Med. Biol., 1996, 15(6), 124.
• [26] HOFMANN G., RUSTRUM W., SUDER K., Electro-incorporation of microcarriers as a method for the transdermal delivery of large molecules, Bioelectrochem Bioenerg., 1995, 38, 209.
• [27] NISHI T., DEV S., YOSHIZATO K., Treatment of cancer using pulsed electric field in combination with chemotherapeutic agents or genes, Human Cell, 1997, 10(1), 81.
• [28] SERSA G., KRANJC S., CEMAZAR M., Improvement of combined modality therapy with cisplatin and radiation using electroporation of tumors, Int. J. Radiat. Oncol. Biol. Phys., 2000, 46(4), 1037.
• [29] WIDERA G., AUSTIN M., RABUSSAY D., Increased DNA vaccine delivery and immunogenicity by electroporation in vivo, J. Immunol., 2000, 164, 4635.
• [30] WIDERA G., DEV N., NOLAN E., Immune responses after DNA vaccination augmented by in vivo electroporation, Keystone Symposium, DNA Vaccines; Immune Responses; Mechanisms and Manipulating Antigen Processing; 12–17.03.1999, Snowbird, UT0.
• [31] Z HANG L., HOFMAN G., L I L., Transderma delivery of genes by pulsed electric fields, Proceedings Bioelectrochem. Bioenerg., 1996, 147.
• [32] Z HANG L., L I L., AN Z., In vivo transdermal delivery of large molecules by pressure-mediated electroincorporation and electroporation; A novel method for drug/gene delivery, Bioelectrochem. Bioenerg., 1997, 42(2), 283